SPAC Update – February 20

– CVII signed LOI with a private company which extended its deadline to May 17 2023
– CCVI signed LOI with a private company which extended its deadline to May 17 2023
– FTAA to liquidate Feb 24, NAV $10.17
– HERA to liquidate Mar 8, NAV $10.17
– FTPA to liquidate Mar 16, NAV $10.13
– MCAE / ETAO deal closed
– NVAC filed DEF14a to extend deadline to Dec 22 2023, vote Mar 10, NAV $10.26
– BNIX filed PRER14a to extend deadline to Mar 14 2024
– IVCB filed PRE14a to extend deadline to Dec 17 2023
– DSAQ filed PRE14a to extend deadline to Mar 28 2024
– AMAO filed PRE14a to extend deadline to Mar 22 2023 (sic)
– TWOA filed PRE14a to extend deadline to Sept 29 2023, vote in Mar, NAV $10.13
– BRKH filed DEFA14a to extend deadline to Dec 15 2023, vote Mar 10, NAV $10.27 but indicated redemption NAV of $10.15
– SCAQ filed DEF14a to extend deadline to Sept 16 2023, vote Mar 10, excise tax to be paid by sponsor
– CHAA stockholders approved deadline extension to Feb 17 2024, 27.8 million shares (92.6%) redeemed, 2.2 million shares remain, NAV $10.18
– GAMC filed DEF14a to extend deadline to Dec 19 2023, vote Mar 15
– JATT filed S-4/a for Zura Bio deal, vote in Mar
– KNSW CEO resigned
– UPTD extended deadline to Mar 19 2023, added $45.5k to trust account
– IGTA filed PRE14a to reduce extension payment, NAV $10.30, Chairman and CEO resigned
– FSRX extension vote
– GXII extension vote